Source:http://linkedlifedata.com/resource/pubmed/id/15505838
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2004-11-1
|
pubmed:abstractText |
The objective of this study was to evaluate the effectiveness of two different closure devices in patients undergoing rescue percutaneous coronary intervention (PCI) using IIb/IIIa inhibitors and to compare it with patients undergoing elective PCI. One hundred sixty-two patients undergoing rescue PCI treated with IIb/IIIa inhibitors underwent vascular access site closure (6 Fr Perclose, n = 92, or 6 Fr Angioseal, n = 70). Vascular complications were compared with a sex- and age-matched group (n = 100) of patients undergoing manual compression after sheath removal and a similar group of patients undergoing elective PCI (n = 196). The incidence of access site complications was not significantly different between the three groups undergoing rescue PCI and was not higher than in patient receiving GP IIb/IIIa inhibitors without fibrinolysis (RR = 0.95; 95% CI = 0.88-1.01). In patients undergoing rescue PCI and receiving IIb/IIIa inhibitors, closure devices allow early sheath removal and are associated with similar outcomes compared with manual compression and elective PCI regardless of the type of closure device used.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activators,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Glycoprotein GPIIb-IIIa...,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator,
http://linkedlifedata.com/resource/pubmed/chemical/reteplase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1522-1946
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
284-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15505838-Aged,
pubmed-meshheading:15505838-Aneurysm, False,
pubmed-meshheading:15505838-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15505838-Female,
pubmed-meshheading:15505838-Femoral Artery,
pubmed-meshheading:15505838-Hematoma,
pubmed-meshheading:15505838-Hemostasis, Surgical,
pubmed-meshheading:15505838-Humans,
pubmed-meshheading:15505838-Logistic Models,
pubmed-meshheading:15505838-Male,
pubmed-meshheading:15505838-Middle Aged,
pubmed-meshheading:15505838-Plasminogen Activators,
pubmed-meshheading:15505838-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:15505838-Prostheses and Implants,
pubmed-meshheading:15505838-Recombinant Proteins,
pubmed-meshheading:15505838-Thrombolytic Therapy,
pubmed-meshheading:15505838-Tissue Plasminogen Activator
|
pubmed:year |
2004
|
pubmed:articleTitle |
Vascular access site complications with the use of closure devices in patients treated with platelet glycoprotein IIb/IIIa inhibitors during rescue angioplasty.
|
pubmed:affiliation |
Cardiology Division, University of Texas Medical School and Memorial Hermann Hospital, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|